Expression of programmed cell death proteins in patients with chronic myeloid leukemia.

Abstract excerpt

PURPOSE: Chronic myelogenous leukemia (CML) is a malignant myeloproliferative disease developing out of pluripotent hematopoietic stem cells that contain the fusion Bcr-Abl gene. The mechanisms that lead to these changes at molecular level are still unknown as are the mechanisms that increase the proliferative capacity of these cells. Disorders that occur in the process of apoptosis represent one of the possible...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alkaline Phosphatase
• Share to bcl-2-Associated X Protein